Agile Therapeutics - 5 Year Stock Split History | AGRX

Stock split history for Agile Therapeutics since 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Agile Therapeutics Annual Stock Splits
Agile Therapeutics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.060B $0.000B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.669B 8.40
Teva Pharmaceutical Industries (TEVA) Israel $14.602B 5.04
Mylan (MYL) United Kingdom $13.853B 5.86
Bausch Health Cos (BHC) Canada $8.091B 5.75
Dr Reddy's Laboratories (RDY) India $6.770B 27.00
Supernus Pharmaceuticals (SUPN) United States $1.887B 17.51
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.523B 2.47
Amphastar Pharmaceuticals (AMPH) United States $0.943B 87.65
Homology Medicines (FIXX) United States $0.832B 0.00
CymaBay Therapeutics (CBAY) United States $0.718B 0.00
Voyager Therapeutics (VYGR) United States $0.626B 0.00
Assembly Biosciences (ASMB) United States $0.423B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.410B 0.00
Akorn (AKRX) United States $0.348B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.172B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.170B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Acasti Pharma (ACST) Canada $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.061B 0.00
Teligent (TLGT) United States $0.044B 0.00
China Pharma Holdings (CPHI) China $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.013B 0.00